BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 1334428)

  • 1. Simultaneous protein expression and modification: an efficient approach for production of unphosphorylated and biotinylated receptor tyrosine kinases by triple infection in the baculovirus expression system.
    Erdmann D; Zimmermann C; Fontana P; Hau JC; De Pover A; Chène P
    J Biomol Tech; 2010 Apr; 21(1):9-17. PubMed ID: 20357977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and purification of functional insulin and insulin-like growth factor 1 holoreceptors from mammalian cells.
    Delle Bovi RJ; Miller WT
    Anal Biochem; 2017 Nov; 536():69-77. PubMed ID: 28830678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downstream processing of insect cell cultures.
    Bernard AR; Lusti-Narasimhan M; Radford KM; Hale RS; Sebille E; Graber P
    Cytotechnology; 1996 Jan; 20(1-3):239-57. PubMed ID: 22358488
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction of class I human leukocyte antigen (HLA-I) molecules with insulin receptors and its effect on the insulin-signaling cascade.
    Ramalingam TS; Chakrabarti A; Edidin M
    Mol Biol Cell; 1997 Dec; 8(12):2463-74. PubMed ID: 9398668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone H4 stimulates glucose transport activity in rat skeletal muscle.
    Louters LL; Henriksen EJ; Tipton CM
    Biochem J; 1993 Oct; 295 ( Pt 2)(Pt 2):549-53. PubMed ID: 8240256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase activity of the insulin receptor.
    Gammeltoft S; Van Obberghen E
    Biochem J; 1986 Apr; 235(1):1-11. PubMed ID: 3017297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, purification, and characterization of the cytoplasmic domain of the human insulin receptor using a baculovirus expression system.
    Herrera R; Lebwohl D; Garcia de Herreros A; Kallen RG; Rosen OM
    J Biol Chem; 1988 Apr; 263(12):5560-8. PubMed ID: 2451671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-scale purification and characterisation of a recombinant epidermal growth-factor receptor protein-tyrosine kinase. Modulation of activity by multiple factors.
    McGlynn E; Becker M; Mett H; Reutener S; Cozens R; Lydon NB
    Eur J Biochem; 1992 Jul; 207(1):265-75. PubMed ID: 1321046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient expression in insect cells of a soluble, active human insulin receptor protein-tyrosine kinase domain by use of a baculovirus vector.
    Ellis L; Levitan A; Cobb MH; Ramos P
    J Virol; 1988 May; 62(5):1634-9. PubMed ID: 2833613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of COOH-terminal and acidic domains in the activity and stability of human insulin receptor protein tyrosine kinase studied by purified deletion mutants of the beta subunit domain.
    Yan PF; Li SL; Liang SJ; Giannini S; Fujita-Yamaguchi Y
    J Biol Chem; 1993 Oct; 268(30):22444-9. PubMed ID: 8226752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and initial characterization of the lymphoid-cell protein-tyrosine kinase p56lck from a baculovirus expression system.
    Ramer SE; Winkler DG; Carrera A; Roberts TM; Walsh CT
    Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6254-8. PubMed ID: 2068105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human insulin receptor beta-subunit transmembrane/cytoplasmic domain expressed in a baculovirus expression system: purification, characterization, and polylysine effects on the protein tyrosine kinase activity.
    Li SL; Yan PF; Paz IB; Fujita-Yamaguchi Y
    Biochemistry; 1992 Dec; 31(49):12455-62. PubMed ID: 1334428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-receptor approaches to studying protein kinase domain.
    Wente SR; Rosen OM
    Diabetes Care; 1990 Mar; 13(3):280-7. PubMed ID: 2155093
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.